¿Qué efecto y seguridad tiene la ciclosporina a dosis bajas, en monoterapia o asociada a esteroides, utilizada como inducción y como tratamiento a largo plazo de la nefropatía membranosa idiopática con síndrome nefrótico?
What are the effectiveness and safety of low-dose Cyclosporin as monotherapy or combined with corticosteroids used as induction and long-term therapy in idiopathic membranous nephropathy with nephrotic syndrome?
X. Fulladosa
Read
7501
Timeswas read the article
2999
Total PDF
4502
Total HTML
Article information
ISSN: 02116995Original language: Spanish
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 11 | 32 | 33 | 65 |
| 2025 10 | 58 | 61 | 119 |
| 2025 9 | 50 | 42 | 92 |
| 2025 8 | 46 | 50 | 96 |
| 2025 7 | 45 | 16 | 61 |
| 2025 6 | 149 | 174 | 323 |
| 2025 5 | 70 | 28 | 98 |
| 2025 4 | 61 | 23 | 84 |
| 2025 3 | 81 | 47 | 128 |
| 2025 2 | 69 | 33 | 102 |
| 2025 1 | 57 | 37 | 94 |
| 2024 12 | 43 | 23 | 66 |
| 2024 11 | 39 | 57 | 96 |
| 2024 10 | 34 | 25 | 59 |
| 2024 9 | 43 | 27 | 70 |
| 2024 8 | 44 | 50 | 94 |
| 2024 7 | 45 | 41 | 86 |
| 2024 6 | 45 | 31 | 76 |
| 2024 5 | 49 | 36 | 85 |
| 2024 4 | 31 | 33 | 64 |
| 2024 3 | 24 | 17 | 41 |
| 2024 2 | 30 | 27 | 57 |
| 2024 1 | 23 | 17 | 40 |
| 2023 12 | 33 | 20 | 53 |
| 2023 11 | 19 | 26 | 45 |
| 2023 10 | 27 | 32 | 59 |
| 2023 9 | 31 | 25 | 56 |
| 2023 8 | 14 | 16 | 30 |
| 2023 7 | 26 | 23 | 49 |
| 2023 6 | 36 | 19 | 55 |
| 2023 5 | 42 | 32 | 74 |
| 2023 4 | 34 | 27 | 61 |
| 2023 3 | 21 | 18 | 39 |
| 2023 2 | 17 | 25 | 42 |
| 2023 1 | 35 | 29 | 64 |
| 2022 12 | 27 | 28 | 55 |
| 2022 11 | 32 | 35 | 67 |
| 2022 10 | 36 | 46 | 82 |
| 2022 9 | 26 | 26 | 52 |
| 2022 8 | 34 | 48 | 82 |
| 2022 7 | 32 | 47 | 79 |
| 2022 6 | 20 | 33 | 53 |
| 2022 5 | 21 | 22 | 43 |
| 2022 4 | 37 | 54 | 91 |
| 2022 3 | 31 | 49 | 80 |
| 2022 2 | 43 | 43 | 86 |
| 2022 1 | 58 | 34 | 92 |
| 2021 12 | 32 | 29 | 61 |
| 2021 11 | 34 | 37 | 71 |
| 2021 10 | 41 | 39 | 80 |
| 2021 9 | 25 | 31 | 56 |
| 2021 8 | 58 | 35 | 93 |
| 2021 7 | 31 | 33 | 64 |
| 2021 6 | 42 | 31 | 73 |
| 2021 5 | 42 | 35 | 77 |
| 2021 4 | 133 | 62 | 195 |
| 2021 3 | 60 | 23 | 83 |
| 2021 2 | 162 | 71 | 233 |
| 2021 1 | 27 | 15 | 42 |
| 2020 12 | 13 | 15 | 28 |
| 2020 11 | 21 | 10 | 31 |
| 2020 10 | 26 | 12 | 38 |
| 2020 9 | 18 | 13 | 31 |
| 2020 8 | 22 | 6 | 28 |
| 2020 7 | 25 | 14 | 39 |
| 2020 6 | 21 | 14 | 35 |
| 2020 5 | 29 | 24 | 53 |
| 2020 4 | 29 | 13 | 42 |
| 2020 3 | 13 | 16 | 29 |
| 2020 2 | 38 | 28 | 66 |
| 2020 1 | 29 | 33 | 62 |
| 2019 12 | 10 | 20 | 30 |
| 2019 11 | 26 | 16 | 42 |
| 2019 10 | 18 | 10 | 28 |
| 2019 9 | 25 | 21 | 46 |
| 2019 8 | 27 | 19 | 46 |
| 2019 7 | 11 | 26 | 37 |
| 2019 6 | 23 | 13 | 36 |
| 2019 5 | 22 | 29 | 51 |
| 2019 4 | 30 | 59 | 89 |
| 2019 3 | 9 | 17 | 26 |
| 2019 2 | 11 | 29 | 40 |
| 2019 1 | 2 | 24 | 26 |
| 2018 12 | 32 | 40 | 72 |
| 2018 11 | 18 | 22 | 40 |
| 2018 10 | 21 | 25 | 46 |
| 2018 9 | 22 | 27 | 49 |
| 2018 8 | 12 | 18 | 30 |
| 2018 7 | 16 | 19 | 35 |
| 2018 6 | 13 | 16 | 29 |
| 2018 5 | 15 | 17 | 32 |
| 2018 4 | 20 | 17 | 37 |
| 2018 3 | 12 | 11 | 23 |
| 2018 2 | 11 | 6 | 17 |
| 2018 1 | 20 | 9 | 29 |
| 2017 12 | 6 | 9 | 15 |
| 2017 11 | 8 | 14 | 22 |
| 2017 10 | 9 | 8 | 17 |
| 2017 9 | 12 | 8 | 20 |
| 2017 8 | 11 | 14 | 25 |
| 2017 7 | 9 | 7 | 16 |
| 2017 6 | 22 | 9 | 31 |
| 2017 5 | 19 | 16 | 35 |
| 2017 4 | 6 | 11 | 17 |
| 2017 3 | 12 | 14 | 26 |
| 2017 2 | 4 | 3 | 7 |
| 2017 1 | 9 | 6 | 15 |
| 2016 12 | 21 | 5 | 26 |
| 2016 11 | 17 | 12 | 29 |
| 2016 10 | 23 | 9 | 32 |
| 2016 9 | 40 | 7 | 47 |
| 2016 8 | 57 | 8 | 65 |
| 2016 7 | 55 | 5 | 60 |
| 2016 6 | 44 | 0 | 44 |
| 2016 5 | 71 | 0 | 71 |
| 2016 4 | 62 | 0 | 62 |
| 2016 3 | 29 | 0 | 29 |
| 2016 2 | 42 | 0 | 42 |
| 2016 1 | 46 | 0 | 46 |
| 2015 12 | 66 | 0 | 66 |
| 2015 11 | 35 | 0 | 35 |
| 2015 10 | 44 | 0 | 44 |
| 2015 9 | 37 | 0 | 37 |
| 2015 8 | 38 | 0 | 38 |
| 2015 7 | 44 | 0 | 44 |
| 2015 6 | 15 | 0 | 15 |
| 2015 5 | 53 | 0 | 53 |
| 2015 4 | 4 | 0 | 4 |
| 2015 2 | 235 | 0 | 235 |
Show all
